People · Operator

Worth Harris

Named in public records as an officer, director or promoter · active 2021–2022 · Agtech / Foodtech, Other Technology

2
Companies
2
Filings
$18.6M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Panaceutics Nutrition, Inc.Agtech / FoodtechSeries A$13.6M$5.9M2022
SinnovaTek, Inc.Other TechnologySeries A$5.0M$92.6M2021
Operator network

Worth Harris at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Mark Friedman · 8 companies · 1 sharedMark FriedmanAdam Monroe · 2 companies · 1 sharedAdam MonroeGregory McParland · 2 companies · 1 sharedGregory McParlandEdison T. Hudson, Jr. · 1 companies · 1 sharedEdison T. Hudson,…Edward Hauck · 1 companies · 1 sharedEdward HauckEdward T. Hauck · 1 companies · 1 sharedEdward T. HauckEva Doss · 1 companies · 1 sharedEva DossMark T. Friedman · 1 companies · 1 sharedMark T. FriedmanTim Hassler · 3 companies · 1 sharedTim HasslerAmanda Vargochik · 2 companies · 1 sharedAmanda VargochikJosip Simunovic · 2 companies · 1 sharedJosip SimunovicMichael Druga · 2 companies · 1 sharedMichael DrugaJim Holbrook · 1 companies · 1 sharedJim HolbrookPanaceutics Nutrition, Inc. · $13.6M raisedPanaceutics Nutrition…SinnovaTek, Inc. · $5.0M raisedSinnovaTek, Inc.Worth HarrisWH
Worth Harris Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Worth Harris on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Mark Friedman18
Tim Hassler13
Michael Druga12
Gregory McParland12
Adam Monroe12
Amanda Vargochik12
Josip Simunovic12
Edward T. Hauck11
Mark T. Friedman11
Jim Holbrook11
Eva Doss11
Edward Hauck11
Edison T. Hudson, Jr.11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.